North East and North Cumbria
ICS Formulary
4 Central nervous system
04-08-01 Levetiracetam
Links
Local Shared Care guideline in TEWV to support Valproate Pregnancy Prevention Programme
MHRA Drug Safety Alert (Feb 2015): Drugs and driving: blood concentration limits set for certain drugs
MHRA Drug Safety Alert (Oct 2017): Gabapentin (Neurontin): risk of severe respiratory depression
MHRA Drug Safety Update (Apr 2022): Pregabalin (Lyrica): findings of safety study on risks during pregnancy
MHRA Drug Safety Update (Feb 2021): Pregabalin (Lyrica): reports of severe respiratory depression
MHRA Drug Safety Update (Nov 2017): Antiepileptic drugs: updated advice on switching between different manufacturers’ products
MHRA Drug Safety Update (Nov 2017): Antiepileptic drugs: updated advice on switching between different manufacturers’ products
NENC Palliative and End of Life Care Symptom Control Guidelines
NICE CG137: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
NICE NG217: Epilepsies in children, young people and adults
NICE NG62: Cerebral palsy in under 25s: assessment and management
NICE TA232: Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation
NICE TA614: Cannabidiol with clobazam for treating seizures associated with Dravet syndrome
NICE TA615: Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome
NICE TA753: Cenobamate for treating focal onset seizures in epilepsy
NICE TA808: Fenfluramine for treating seizures associated with Dravet syndrome
NICE TA873: Cannabidiol for treating seizures caused by tuberous sclerosis complex
North of Tyne, Gateshead and North Cumbria - Vigabatrin Shared Care Guideline
NTAG - Perampanel (Fycompa®) for epilepsy
TEWV - Medicines Optimisation – Interactive Guide
TEWV Guidelines
TEWV Safe Transfer of Prescribing Guidance
Valproate medicines: Pregnancy Prevention Programme materials
Key
Full Site